PHYSICOCHEMICAL BASIS OF THE BUFFERED ACETYLSALICYLIC ACID CONTROVERSY

被引:284
作者
LEVY, G
HAYES, BA
机构
关键词
D O I
10.1056/NEJM196005262622102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1053 / 1058
页数:6
相关论文
共 57 条
[1]   COMPARISON OF BUFFERED AND UNBUFFERED ACETYLSALICYLIC ACID [J].
BATTERMAN, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1958, 258 (05) :213-219
[2]  
BATTERMAN RC, 1956, FED PROC, V15, P398
[3]  
BOLDT F, 1954, Med Klin, V49, P150
[4]  
Bradley WB, 1936, AM J DIG DIS, V3, P415
[5]   SALICYLATE TOXICITY - THE PROBABLE MECHANISM OF ITS ACTION [J].
CARAVATI, CM ;
COSGROVE, EF .
ANNALS OF INTERNAL MEDICINE, 1946, 24 (04) :638-642
[6]   PLASMA LEVELS AFTER THE ORAL ADMINISTRATION OF ACETYLSALICYLIC ACID AND N-ACETYL-PARA-AMINOPHENOL IN DIFFERENT FORMS TO HUMAN SUBJECTS [J].
CARLO, PE ;
CAMBOSOS, NM ;
FEENEY, GC ;
SMITH, PK .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1955, 44 (07) :396-399
[7]   THE RELATION BETWEEN INVITRO DISINTEGRATION TIME OF SUGAR-COATED TABLETS AND PHYSIOLOGICAL AVAILABILITY OF RIBOFLAVIN [J].
CHAPMAN, DG ;
CRISAFIO, R ;
CAMPBELL, JA .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION-SCIENTIFIC EDITION, 1954, 43 (05) :297-304
[8]  
CLARK BB, 1947, GASTROENTEROLOGY, V9, P461
[10]  
Douthwaite AH, 1938, LANCET, V2, P1222